Drug Shortage Report for LUTREPULSE

Last updated on 2019-01-11 History
Report ID 4516
Drug Identification Number 02046202
Brand name LUTREPULSE
Common or Proper name LUTREPULSE
Company Name FERRING INC
Active Ingredient(s) GONADORELIN ACETATE
Strength(s) 3.2MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS
Packaging size 3 VIALS 3.2 MG LUTREPULSE FOR INJECTION
ATC code H01CA
ATC description HYPOTHALAMIC HORMONES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2017-03-28
Estimated end date
Actual end date 2019-01-10
Shortage status Resolved
Updated date 2019-01-11
Company comments Duplicate listing of report ID 4514. Resolved
Health Canada comments
Contact Address 200 YORKLAND BLVD, SUITE 500
NORTH YORK, ONTARIO
CANADA M2J 5C1
Company contact information 1-800-263-4057

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2019-01-11 English Compare
v18 2019-01-10 French Compare
v17 2019-01-10 English Compare
v16 2019-01-10 French Compare
v15 2019-01-10 English Compare
v14 2019-01-10 English Compare
v13 2019-01-10 French Compare
v12 2019-01-10 English Compare
v11 2019-01-10 French Compare
v10 2019-01-10 English Compare
v9 2018-07-16 French Compare
v8 2018-07-16 English Compare
v7 2018-03-15 French Compare
v6 2018-03-15 English Compare
v5 2018-01-09 French Compare
v4 2018-01-09 English Compare
v3 2017-03-29 English Compare
v2 2017-03-28 French Compare
v1 2017-03-28 English Compare